Luis Rosero Bixby
Permanent URI for this collectionhttps://repositorio.sibdi.ucr.ac.cr/handle/123456789/16105
Browse
2 results
Search Results
Now showing 1 - 2 of 2
Item Confirmación histológica del diagnóstico de cáncer cérvico uterino en Costa Rica 1982-84(Acta Médica Costarricense, Vol. 33; No, 3, 1990) Oberle, Mark W.; Rosero Bixby, Luis; Saeed, MekbelUn panel de patólogos costarricenses efectuó un análisis histológico de las biopsias de 677 casos de cáncer de cuello de útero in situ e invasor diagnosticados en Costa Rica en 1982 - 1984. El panel confirmó el diagnóstico inicial del 81% de los casos de cáncer in situ y del 72% de los casos de cáncer invasor. El panel redigo la severidad del diagnóstico a displasia u otra lesión no cancerosa en el 12% de los casos de cáncer in situ y en el 3% de los casos de cáncer invasor. El 8% de los casos de cáncer invasor fueron reclasificados como in situ. Un 9% adicional podrían ser reclasificados en el mismo sentido, pero hay dudas sobre el diagnóstico definitivo. El error más grave ocurrió en 3% de los casos Inicialmente diagnosticados como de cáncer in situ los cuales fueron reclasificados por el panel como cáncer invasor, pero este error probablemente no afectó el tratamiento de las pacientes. Las modificaciones en el diagnóstico obtenidos en el presente estudio pueden derivarse de un examen más cuidadoso efectuado por el panel o de la dificultad propia del diagnóstico histológico del cáncer de cuello de útero.Item A case-control study of breast cancer and hormonal contraception in Costa Rica(JNCI, vol. 7, no. 1 (december 1987), 1987) Lee, Nancy C.; Rosero Bixby, Luis; Oberle, Mark W.; Grimaldo, Carmen; Whatley, Anne S.; Rovira, Elizabeth Z.By 1981, 11% of married women in Costa Rica ages 20-49 years had used depot-medroxyprogesterone acetate (DMPA) and 58% had used oral contraceptives (OCs). Since 1977, the Costa Rican Ministry of Health has maintained a nationwide cancer registry. These circumstances provided an opportunity for a population-based, case-control study of DMPA, OCs, and breast cancer in Costa Rica. Cases were 171 women ages 25-58 years with breast cancer diagnosed between 1982 and 1984; controls were 826 women randomly chosen during a nationwide household survey. Cases and controls were interviewed with the use of a standard questionnaire covering their reproductive and contraceptive histories. Logistic regression methods were used to adjust for confounding factors. While few cases or controls had ever used DMPA, DMPA users had an elevated relative risk (RR) estimate of breast cancer of 2.6 (95% confidence limits = 1.4-4.7) compared with never users. However, no do'se-response relationship was found; even the group of women who had used DMPA for less than 1 year had an elevated RR estimate (RR = 2.3; 95% confidence limits = 1.0-5.1). In contrast, OC users had no elevation in RR compared with never users (RR = 1.2; 95% confidence limits= 0.8-1.8). The results of the DMPA analysis are inconclusive. Before decisions are made on whether to continue providing this effective contraceptive method, other ongoing studies will need to confirm of refute these findings.—JNCI 1987; 79:1247-1254.